Sotatercept-csrk was first approved in 2024 to treat pulmonary arterial hypertension (PAH) in adults based on results seen in the phase 3 STELLAR trial.

Welcome to the inaugural issue of the Food Exec Brief — our new weekly roundup of key headlines for food manufacturing ...

The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and ...

The Transportation Security Administration has a long list of banned items. Some have conditions and some require you check ...

One of the concerns people have when they hear FDA is using AI in the drug approval process is that many people don't have a ...

Los Angeles dental care experiences transformational advancement with Sargon Dental's announcement of Diamoneers technology ...

Nipocalimab's FDA approval revolutionizes generalized myasthenia gravis treatment, offering rapid symptom relief and improved ...

Chronic tinnitus is a frustrating condition that affects millions worldwide, characterized by persistent ringing or buzzing ...

In today’s fast-paced world, maintaining optimal health and well-being can often feel like a daunting challenge, especially ...

The FDA has approved required updates to the labeling of Pfizer’s Comirnaty and Moderna’s Spikevax COVID-19 vaccines to include revised warnings about the risk of myocarditis and pericarditis ...

Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development, marketing, and sale of innovative treatments and therapies, including those for ...